Coloplast As B Dkk 1 (CLPBF) 75.6100 $CLPBF
Identifying Opportunity, Placing Risk -- Free Research on Balfour Beatty, City Developments, Coloplast, and Treasury Wine Estates
ACCESSWIRE - Mon Jan 25, 7:20AM CST
NEW YORK, NY / ACCESSWIRE / January 25, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Balfour Beatty Plc (OTC: BAFYY), City Developments Ltd. (OTC: CDEVY), Coloplast AS (OTC: CLPBY) and Treasury Wine Estates Ltd. (OTC: TSRYY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Leading 200 Global Multinational Medical Devices/Technology/Supplies Companies with Major Manufacturing and R&D
M2 - Thu Oct 22, 2:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nngj7n/_global) has announced the addition of the " Global Geographic Frontiers Medical Devices/Technology/Supplies 200 " report to their offering. The newly launched report identifies 200 global multinational medical devices/technology/supplies companies with manufacturing and research, and covers various analyses to identify countries that should be considered by such companies for new medical devices manufacturing and research. When it comes to medical device product development, the fragmentation of the industry can be challenging. Medical device development and manufacturing have seen many changes in the last decade. Not too long ago, manufacturing anything in a different country was risky and time intensive but now new communication technologies have allowed for the rapid development and manufacturing of medical devices overseas which has reduced costs and time to market. Developed and developing countries are investing in high quality medical device manufacturing facilities that allow sourcing of design and manufacturing throughout the world. However, recently, the medical device manufacturers have also been looking beyond their traditional markets in the United States and EU, focusing instead on emerging economies such as Brazil, Russia, India, and Chinacollectively known as the BRIC nations for growth. But as companies flock to the BRICs and the medtech markets in these countries mature, forward-thinking device makers are searching for the next group of emerging medtech markets. Among those that show promise are the 10 countries that comprise the Association of Southeast Asian Nations (ASEAN)Indonesia, Malaysia, the Philippines, Singapore, Thailand, Brunei, Myanmar, Cambodia, Laos, and Vietnam. Highlights - Identifies leading global multinational medical devices/technology/supplies companies with major manufacturing and R&D - Identifies top 200 among such companies based on total sales, net income, total assets, and total equity - Identifies home and foreign countries for manufacturing and research facilities of leading global geographic frontiers medical devices/technology/supplies companies - Summary of company news for expansion into new countries for leading global medical devices/ technology/supplies companies - Summary of initiatives taken up by government countries to support setting up of manufacturing facilities - Comprehensive listing of leading global geographic frontiers medical devices/technology/supplies companies covered in the study Key Topics Covered: 1: GMD Sales, R&D Expenses, and Foreign Sales for Top 25 Countries by Population 2: Leading 200 Global Multinational Medical Devices/Technology/Supplies Companies with Major Manufacturing and R&D (based on total sales, net income, total assets, total equity) 3: Home Countries having Manufacturing Units in Foreign Countries 4: Home Countries having Research & Development Units in Foreign Countries 5: Popular Foreign Countries for Manufacturing Units 6: Popular Foreign Countries for Research & Development Units 7: Comparison of Manufacturing and Research & Development Units of Home and Foreign Companies in Home Countries 8: Global Medical Devices/Technology/Supplies Companies which Expanded into New Countries in Last 2 Years 9: Government Initiatives to Support Setting Up of Manufacturing Facilities for Medical Devices/Technology/Supplies Companies Mentioned - Partial List - Biotage AB - Boston Scientific Corporation - Boule Diagnostics AB - Bruker Corporation - CRH Medical Corp. - Cambridge Cognition Holdings Plc - Cardica, Inc. - Carl Zeiss Meditec AG - Cellavision AB - Coloplast AS - Coltene Holding AG - Comet Holding AG - Conmed Corporation - Consort Medical Plc - ContextVision - Cooper Companies, Inc. - Cormedix - Covidien Plc - Cutera, Inc. - Cyberoptics Corporation - Cyclopharm Limited - Cynosure Inc - Danaher Corp. - Dentsply International Incorporated - DiaSorin Inc. - Dipped Products Plc - Draegerwerk AG & Co KGaA - EKF Diagnostics Holdings PLC For more information visit http://www.researchandmarkets.com/research/nngj7n/_global
CYNO: 52.65 (+2.41), CRHM: 3.30 (-0.14), DHR: 100.16 (+0.71), COO: 164.92 (-0.10), BSX: 22.80 (+0.17), CRDC: 2.70 (+0.05)
Global Bioactive Wound Care (Alginates, Hydrogel, Collagen, Chitin/Chitosan) Market Analysis 2015-2020
M2 - Tue Sep 15, 4:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rpsc4t/bioactive_wound) has announced the addition of the "Bioactive Wound Care Market Analysis (2015 - 2020); By Type (Alginates, Hydrogel, Collagen, Chitin/Chitosan); By Materials (Ionic Silver, Amniotic Membranes, Egg Membranes)" report to their offering. The Bioactive Wound Care market will grow at a CAGR of 6.5% between 2015-2020. The Bio active Wound Care Devices are used to treat chronic wounds such as venous or arterial ulcers and diabetic foot ulcers. The Bioactive Wound Care is used to treat ulcers without the use of surgical methods such as stapling. The focus is on natural healing of the ulcer through the development of granulation tissue, wound contraction and epithelialization. The biological wound dressings work upon the wounded area to start the healing process. The biological dressings are able to reduce the alkalinity and maintain a neutral pH. The biological dressings absorb exudates which help to maintain the moisture around the wound. The re-epithelialisation is only possible if there is a controlled environment with required humidity, pH and oxygen. The Bioactive Wound Care Market is developing with the introduction of new and advanced technologies. The geriatric population is on the rise, which is most susceptible to skin wounds. The increased awareness about healthcare and the growing demand for bioactive material will boost the market. The market is also driven by the increased use of tissue replacement therapy or grafting. Chronic Diseases such as diabetes, cancer cause wounds, which lead to increased use of bioactive wound dressings. In terms of geography, the North America has the biggest market share accompanied by European region. The increased per capita spending on Healthcare and demographic shift towards aging population is driving the Bioactive Wound Care market. Asia Pacific region will see the largest growth due to increasing population, demand for better and advanced healthcare and high disposable income. Key Topics Covered: 1. Bioactive Wound Care Market - Market Overview 2. Executive Summary 3. Bioactive Wound Care Market - Market Landscape 4. Bioactive Wound Care Market - Market Forces 5. Bioactive Wound Care Market - Strategic Analysis 6. Bioactive Wound Care Market - By Type 7. Bioactive Wound Care Market - By Material Used 8. Global Bioactive Wound Care Market -Geographic Analysis 9. Market Entropy 10. Company Profiles (Overview, Financials, Strategy, Developments, Product Portfolio) - Smith & Nephew plc. - M Corporation - Coloplast AS - ConvaTec Inc. - Johnson & Johnson - Novartis Pharma AG. - AlloSource - Covidien Ltd. - Olympus Corp. - Cook Biotech Inc. - Wright Medical Group, Inc - Synovis Life Technologies, Inc. - Integra LifeSciences Holdings Corp. - Kinetic Concepts, Inc. - Mediwound Ltd. - BioSpecifics Technologies Corp. - Celleration, Inc. - Molnlycke Healthcare Group - Teva Pharmaceutical Industries Ltd. - Healthpoint Biotherapeutics Ltd. - Kaken Pharmaceutical CoLtd. - Shire Plc - Paul Hartmann AG For more information visit http://www.researchandmarkets.com/research/rp...tive_wound
SNN: 34.35 (-0.12), JNJ: 115.80 (+0.07), IARTV: 65.00 (-37.45), SHPG: 188.62 (-3.40), COV: 106.71 (-1.36), WMGIZ: 1.40 (unch), TEVA: 53.99 (-0.07), NVS: 81.39 (-0.22)
Leading 100 Global Medical Supplies Companies 2015
M2 - Mon Mar 23, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9tqljh/global_medical) has announced the addition of the "Global Medical Supplies 100 - An Industry Report" report to their offering. Global demand for disposable medical supplies is projected to grow 6.4 percent annually to nearly $200 billion in 2016. The range of disposable medical supplies consumed worldwide extends into 11 major product segments and eight additional product lines. Among the major product segments, world demand in 2016 will range from $7.5 billion for patient room supplies to $32.2 billion for surgical instruments and supplies. The medical supplies industry is essentially a growth industry. Value line divides the group into medical supplies invasive and medical supplies non invasive. Affordability by patients, increased awareness on health care, improved hospital infrastructure, and the increased disease patterns are listed as the primary drivers boosting the growth of medical equipment and supplies industry. Free market environment, a developed industry, and investment in health infrastructure are amongst other factors that enhance the growth of high quality medical equipments and supplies industry. Report Highlights: - Leading 100 medical supplies companies globally - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among leading global medical supplies companies - International presence of global medical supplies companies - R&D activities by global medical supplies companies Key Topics Covered: 1: Rankings of Medical Supplies Companies Globally 1.1: Leading 100 Medical Supplies Companies Globally (based on recent sales, net income, total assets, total equity) 1.2: Most Growing 25 Medical Supplies Companies Globally 1.3: Most Profitable 25 Medical Supplies Companies Globally 2: Stock Market Performance over 5 Years: Leading 25 Medical Supplies Companies Globally 3: Key News of Medical Supplies Sector Globally for Year 2014 3.1 - Key Company News: By Country and Company 3.2 - Key Company News: By News Category 3.3 - Key Industry News: By News Category 4: Important Alliances among Leading Medical Supplies Companies Globally 5: International Presence of Global Medical Supplies Companies 6: Research and Development Activities by Global Medical Supplies Companies 7: Mergers and Acquisitions among Global Medical Supplies Companies Companies Mentioned (Partial List) - 3M Company (United States) - Angiodynamics, Inc. (United States) - Baxter International Inc. (United States) - C R Bard Inc (United States) - Carefusion Corporation (United States) - Coloplast AS (Denmark) - Cooper Companies Inc (United States) - Covidien Plc (Ireland) - Elekta publ AB (United States) - Essilor International Compagnie Generale D'optique Sa (Sweden) - Getinge AB (France) - Hartalega Holdings Bhd (Sweden) - Koninklijke Philips NV (Malaysia) - Medcomtech SA (Netherlands) - Nitto Denko (Spain) - Ossur hf. (Iceland) - Otsuka Pharmaceutical Co., Ltd. (Japan) - Prim, S.A. (Spain) - Sonova Holding AG (Switzerland) - William Demant Holding (Denmark) - Ypsomed Holding AG (Switzerland) For more information visit http://www.researchandmarkets.com/research/9t...al_medical
MMM: 171.42 (+0.51), BAX: 44.60 (+0.67), COO: 164.92 (-0.10)
Top 100 Foreign Medical Devices/Technology/Supplies Companies Active in India: 2015
M2 - Mon Mar 09, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9rw4tk/foreign_medical) has announced the addition of the "Foreign Medical Devices/Technology/Supplies Active in India 100: An Industry Report" report to their offering. In India, with a rising population level and higher national growth rates and income levels, the demand for medical devices is expected to grow at a rate of over 15% per year. India's free market environment, developed industry, investment in health infrastructure, increased demand for high quality medical devices, and agreements between foreign device manufacturers and Indian manufacturers are some of the main factors that are responsible for the growth of the Indian medical market. In a bid to boost investment in the $7 billion medical device sector, the Indian government announced that foreign companies could now fully own existing medical device manufacturers in the country, without the need to get prior approvals. This easing of existing regulations has been done to encourage foreign direct investment since the domestic capital market was not able to provide the much needed investment in this sector. However, there are presently a sizable number of foreign firms actively pursuing their businesses in India in this sector. The international companies in this field are using India as a manufacturing base by either setting up facilities of their own or by acquiring domestic manufacturers. And, FDI inflow will spur R&D and manufacturing innovations, in turn increasing the efficiency and effectiveness of medical electronic products. Advancement of medical electronic product quality and associated successful diagnostic rates are expected to create a spurt in adoption. These 100 foreign companies are a stepping-stone to enter India and therefore this report would be beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices/technology/supplies companies of foreign countries active in India - Integration of company news and industry news, as well as rankings - Important M&A and alliances with Indian companies - India presence of foreign medical devices/technology/supplies companies - R&D activities by foreign medical devices/technology/supplies companies in India Companies Mentioned - Accuray Inc (United States) - Accuray medical equipment (India) Private Limited - Alcon Japan Ltd.(Japan) - Alcon Laboratories (India) Pvt. Ltd. - Alpha Pro Tech Limited (Canada) - Ambu A/S (Denmark) - Ambu India - Amplifon India Pvt. Ltd. - Amplifon SPA (Italy) - Asahi Intecc Co., Ltd. (Japan) - B. Braun Aesculap Japan Co., Ltd.(Japan) - B.Braun Medical India Pvt. Ltd. - B.L.J. Company Limited(Japan) - BD India Pvt. Ltd. - Bard India Healthcare Private Limited - Bausch & Lomb Eyecare (India) Pvt. Ltd. - Becton, Dickinson and Company (United States) - Boston Scientific Corporation (United States) - Boston Scientific India Pvt. Ltd. - C R Bard Inc (United States) - CHC Group India - CHC Healthcare Group (Taiwan) - CareFusion Development Pvt. Ltd. - Carefusion Corporation (United States) - Coloplast (India) Pvt. Ltd. - Coloplast AS (Denmark) - Coltene Holding AG (Switzerland) - Coltene/Whaledent Private Ltd. - Conmed Corporation (United States) For more information visit http://www.researchandmarkets.com/research/9r...gn_medical
BSX: 22.80 (+0.17), CFN: 59.91 (-0.06), APT: 2.48 (+0.01), ARAY: 5.67 (+0.06)
Identifying Opportunity, Placing Risk -- Free Research on Balfour Beatty, City Developments, Coloplast, and Treasury Wine Estates
ACCESSWIRE - Mon Jan 25, 7:20AM CST
NEW YORK, NY / ACCESSWIRE / January 25, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Balfour Beatty Plc (OTC: BAFYY), City Developments Ltd. (OTC: CDEVY), Coloplast AS (OTC: CLPBY) and Treasury Wine Estates Ltd. (OTC: TSRYY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Leading 200 Global Multinational Medical Devices/Technology/Supplies Companies with Major Manufacturing and R&D
M2 - Thu Oct 22, 2:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nngj7n/_global) has announced the addition of the " Global Geographic Frontiers Medical Devices/Technology/Supplies 200 " report to their offering. The newly launched report identifies 200 global multinational medical devices/technology/supplies companies with manufacturing and research, and covers various analyses to identify countries that should be considered by such companies for new medical devices manufacturing and research. When it comes to medical device product development, the fragmentation of the industry can be challenging. Medical device development and manufacturing have seen many changes in the last decade. Not too long ago, manufacturing anything in a different country was risky and time intensive but now new communication technologies have allowed for the rapid development and manufacturing of medical devices overseas which has reduced costs and time to market. Developed and developing countries are investing in high quality medical device manufacturing facilities that allow sourcing of design and manufacturing throughout the world. However, recently, the medical device manufacturers have also been looking beyond their traditional markets in the United States and EU, focusing instead on emerging economies such as Brazil, Russia, India, and Chinacollectively known as the BRIC nations for growth. But as companies flock to the BRICs and the medtech markets in these countries mature, forward-thinking device makers are searching for the next group of emerging medtech markets. Among those that show promise are the 10 countries that comprise the Association of Southeast Asian Nations (ASEAN)Indonesia, Malaysia, the Philippines, Singapore, Thailand, Brunei, Myanmar, Cambodia, Laos, and Vietnam. Highlights - Identifies leading global multinational medical devices/technology/supplies companies with major manufacturing and R&D - Identifies top 200 among such companies based on total sales, net income, total assets, and total equity - Identifies home and foreign countries for manufacturing and research facilities of leading global geographic frontiers medical devices/technology/supplies companies - Summary of company news for expansion into new countries for leading global medical devices/ technology/supplies companies - Summary of initiatives taken up by government countries to support setting up of manufacturing facilities - Comprehensive listing of leading global geographic frontiers medical devices/technology/supplies companies covered in the study Key Topics Covered: 1: GMD Sales, R&D Expenses, and Foreign Sales for Top 25 Countries by Population 2: Leading 200 Global Multinational Medical Devices/Technology/Supplies Companies with Major Manufacturing and R&D (based on total sales, net income, total assets, total equity) 3: Home Countries having Manufacturing Units in Foreign Countries 4: Home Countries having Research & Development Units in Foreign Countries 5: Popular Foreign Countries for Manufacturing Units 6: Popular Foreign Countries for Research & Development Units 7: Comparison of Manufacturing and Research & Development Units of Home and Foreign Companies in Home Countries 8: Global Medical Devices/Technology/Supplies Companies which Expanded into New Countries in Last 2 Years 9: Government Initiatives to Support Setting Up of Manufacturing Facilities for Medical Devices/Technology/Supplies Companies Mentioned - Partial List - Biotage AB - Boston Scientific Corporation - Boule Diagnostics AB - Bruker Corporation - CRH Medical Corp. - Cambridge Cognition Holdings Plc - Cardica, Inc. - Carl Zeiss Meditec AG - Cellavision AB - Coloplast AS - Coltene Holding AG - Comet Holding AG - Conmed Corporation - Consort Medical Plc - ContextVision - Cooper Companies, Inc. - Cormedix - Covidien Plc - Cutera, Inc. - Cyberoptics Corporation - Cyclopharm Limited - Cynosure Inc - Danaher Corp. - Dentsply International Incorporated - DiaSorin Inc. - Dipped Products Plc - Draegerwerk AG & Co KGaA - EKF Diagnostics Holdings PLC For more information visit http://www.researchandmarkets.com/research/nngj7n/_global
CYNO: 52.65 (+2.41), CRHM: 3.30 (-0.14), DHR: 100.16 (+0.71), COO: 164.92 (-0.10), BSX: 22.80 (+0.17), CRDC: 2.70 (+0.05)
Global Bioactive Wound Care (Alginates, Hydrogel, Collagen, Chitin/Chitosan) Market Analysis 2015-2020
M2 - Tue Sep 15, 4:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rpsc4t/bioactive_wound) has announced the addition of the "Bioactive Wound Care Market Analysis (2015 - 2020); By Type (Alginates, Hydrogel, Collagen, Chitin/Chitosan); By Materials (Ionic Silver, Amniotic Membranes, Egg Membranes)" report to their offering. The Bioactive Wound Care market will grow at a CAGR of 6.5% between 2015-2020. The Bio active Wound Care Devices are used to treat chronic wounds such as venous or arterial ulcers and diabetic foot ulcers. The Bioactive Wound Care is used to treat ulcers without the use of surgical methods such as stapling. The focus is on natural healing of the ulcer through the development of granulation tissue, wound contraction and epithelialization. The biological wound dressings work upon the wounded area to start the healing process. The biological dressings are able to reduce the alkalinity and maintain a neutral pH. The biological dressings absorb exudates which help to maintain the moisture around the wound. The re-epithelialisation is only possible if there is a controlled environment with required humidity, pH and oxygen. The Bioactive Wound Care Market is developing with the introduction of new and advanced technologies. The geriatric population is on the rise, which is most susceptible to skin wounds. The increased awareness about healthcare and the growing demand for bioactive material will boost the market. The market is also driven by the increased use of tissue replacement therapy or grafting. Chronic Diseases such as diabetes, cancer cause wounds, which lead to increased use of bioactive wound dressings. In terms of geography, the North America has the biggest market share accompanied by European region. The increased per capita spending on Healthcare and demographic shift towards aging population is driving the Bioactive Wound Care market. Asia Pacific region will see the largest growth due to increasing population, demand for better and advanced healthcare and high disposable income. Key Topics Covered: 1. Bioactive Wound Care Market - Market Overview 2. Executive Summary 3. Bioactive Wound Care Market - Market Landscape 4. Bioactive Wound Care Market - Market Forces 5. Bioactive Wound Care Market - Strategic Analysis 6. Bioactive Wound Care Market - By Type 7. Bioactive Wound Care Market - By Material Used 8. Global Bioactive Wound Care Market -Geographic Analysis 9. Market Entropy 10. Company Profiles (Overview, Financials, Strategy, Developments, Product Portfolio) - Smith & Nephew plc. - M Corporation - Coloplast AS - ConvaTec Inc. - Johnson & Johnson - Novartis Pharma AG. - AlloSource - Covidien Ltd. - Olympus Corp. - Cook Biotech Inc. - Wright Medical Group, Inc - Synovis Life Technologies, Inc. - Integra LifeSciences Holdings Corp. - Kinetic Concepts, Inc. - Mediwound Ltd. - BioSpecifics Technologies Corp. - Celleration, Inc. - Molnlycke Healthcare Group - Teva Pharmaceutical Industries Ltd. - Healthpoint Biotherapeutics Ltd. - Kaken Pharmaceutical CoLtd. - Shire Plc - Paul Hartmann AG For more information visit http://www.researchandmarkets.com/research/rp...tive_wound
SNN: 34.35 (-0.12), JNJ: 115.80 (+0.07), IARTV: 65.00 (-37.45), SHPG: 188.62 (-3.40), COV: 106.71 (-1.36), WMGIZ: 1.40 (unch), TEVA: 53.99 (-0.07), NVS: 81.39 (-0.22)
Leading 100 Global Medical Supplies Companies 2015
M2 - Mon Mar 23, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9tqljh/global_medical) has announced the addition of the "Global Medical Supplies 100 - An Industry Report" report to their offering. Global demand for disposable medical supplies is projected to grow 6.4 percent annually to nearly $200 billion in 2016. The range of disposable medical supplies consumed worldwide extends into 11 major product segments and eight additional product lines. Among the major product segments, world demand in 2016 will range from $7.5 billion for patient room supplies to $32.2 billion for surgical instruments and supplies. The medical supplies industry is essentially a growth industry. Value line divides the group into medical supplies invasive and medical supplies non invasive. Affordability by patients, increased awareness on health care, improved hospital infrastructure, and the increased disease patterns are listed as the primary drivers boosting the growth of medical equipment and supplies industry. Free market environment, a developed industry, and investment in health infrastructure are amongst other factors that enhance the growth of high quality medical equipments and supplies industry. Report Highlights: - Leading 100 medical supplies companies globally - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among leading global medical supplies companies - International presence of global medical supplies companies - R&D activities by global medical supplies companies Key Topics Covered: 1: Rankings of Medical Supplies Companies Globally 1.1: Leading 100 Medical Supplies Companies Globally (based on recent sales, net income, total assets, total equity) 1.2: Most Growing 25 Medical Supplies Companies Globally 1.3: Most Profitable 25 Medical Supplies Companies Globally 2: Stock Market Performance over 5 Years: Leading 25 Medical Supplies Companies Globally 3: Key News of Medical Supplies Sector Globally for Year 2014 3.1 - Key Company News: By Country and Company 3.2 - Key Company News: By News Category 3.3 - Key Industry News: By News Category 4: Important Alliances among Leading Medical Supplies Companies Globally 5: International Presence of Global Medical Supplies Companies 6: Research and Development Activities by Global Medical Supplies Companies 7: Mergers and Acquisitions among Global Medical Supplies Companies Companies Mentioned (Partial List) - 3M Company (United States) - Angiodynamics, Inc. (United States) - Baxter International Inc. (United States) - C R Bard Inc (United States) - Carefusion Corporation (United States) - Coloplast AS (Denmark) - Cooper Companies Inc (United States) - Covidien Plc (Ireland) - Elekta publ AB (United States) - Essilor International Compagnie Generale D'optique Sa (Sweden) - Getinge AB (France) - Hartalega Holdings Bhd (Sweden) - Koninklijke Philips NV (Malaysia) - Medcomtech SA (Netherlands) - Nitto Denko (Spain) - Ossur hf. (Iceland) - Otsuka Pharmaceutical Co., Ltd. (Japan) - Prim, S.A. (Spain) - Sonova Holding AG (Switzerland) - William Demant Holding (Denmark) - Ypsomed Holding AG (Switzerland) For more information visit http://www.researchandmarkets.com/research/9t...al_medical
MMM: 171.42 (+0.51), BAX: 44.60 (+0.67), COO: 164.92 (-0.10)
Top 100 Foreign Medical Devices/Technology/Supplies Companies Active in India: 2015
M2 - Mon Mar 09, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9rw4tk/foreign_medical) has announced the addition of the "Foreign Medical Devices/Technology/Supplies Active in India 100: An Industry Report" report to their offering. In India, with a rising population level and higher national growth rates and income levels, the demand for medical devices is expected to grow at a rate of over 15% per year. India's free market environment, developed industry, investment in health infrastructure, increased demand for high quality medical devices, and agreements between foreign device manufacturers and Indian manufacturers are some of the main factors that are responsible for the growth of the Indian medical market. In a bid to boost investment in the $7 billion medical device sector, the Indian government announced that foreign companies could now fully own existing medical device manufacturers in the country, without the need to get prior approvals. This easing of existing regulations has been done to encourage foreign direct investment since the domestic capital market was not able to provide the much needed investment in this sector. However, there are presently a sizable number of foreign firms actively pursuing their businesses in India in this sector. The international companies in this field are using India as a manufacturing base by either setting up facilities of their own or by acquiring domestic manufacturers. And, FDI inflow will spur R&D and manufacturing innovations, in turn increasing the efficiency and effectiveness of medical electronic products. Advancement of medical electronic product quality and associated successful diagnostic rates are expected to create a spurt in adoption. These 100 foreign companies are a stepping-stone to enter India and therefore this report would be beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices/technology/supplies companies of foreign countries active in India - Integration of company news and industry news, as well as rankings - Important M&A and alliances with Indian companies - India presence of foreign medical devices/technology/supplies companies - R&D activities by foreign medical devices/technology/supplies companies in India Companies Mentioned - Accuray Inc (United States) - Accuray medical equipment (India) Private Limited - Alcon Japan Ltd.(Japan) - Alcon Laboratories (India) Pvt. Ltd. - Alpha Pro Tech Limited (Canada) - Ambu A/S (Denmark) - Ambu India - Amplifon India Pvt. Ltd. - Amplifon SPA (Italy) - Asahi Intecc Co., Ltd. (Japan) - B. Braun Aesculap Japan Co., Ltd.(Japan) - B.Braun Medical India Pvt. Ltd. - B.L.J. Company Limited(Japan) - BD India Pvt. Ltd. - Bard India Healthcare Private Limited - Bausch & Lomb Eyecare (India) Pvt. Ltd. - Becton, Dickinson and Company (United States) - Boston Scientific Corporation (United States) - Boston Scientific India Pvt. Ltd. - C R Bard Inc (United States) - CHC Group India - CHC Healthcare Group (Taiwan) - CareFusion Development Pvt. Ltd. - Carefusion Corporation (United States) - Coloplast (India) Pvt. Ltd. - Coloplast AS (Denmark) - Coltene Holding AG (Switzerland) - Coltene/Whaledent Private Ltd. - Conmed Corporation (United States) For more information visit http://www.researchandmarkets.com/research/9r...gn_medical
BSX: 22.80 (+0.17), CFN: 59.91 (-0.06), APT: 2.48 (+0.01), ARAY: 5.67 (+0.06)
